Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.
暂无分享,去创建一个
Harry J de Koning | Madeleine M A Tilanus-Linthorst | Ellen Warner | Martin O Leach | Francesco Sardanelli | Geertruida H de Bock | Edwin R van den Heuvel | Nehmat Houssami | E. R. van den Heuvel | H. D. de Koning | T. Helbich | M. Hooning | N. Houssami | M. Leach | E. Warner | I. Obdeijn | M. Tilanus-Linthorst | F. Sardanelli | G. D. de Bock | I. Trop | C. Riedl | Maartje J Hooning | Isabelle Trop | Xuan-Anh Phi | Sepideh Saadatmand | Christopher C Riedl | Thomas H Helbich | Xuan-Anh Phi | S. Saadatmand | Inge-Marie Obdeijn
[1] E. R. van den Heuvel,et al. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] A Russell Localio,et al. Multimodality screening of high-risk women: a prospective cohort study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Constantine Gatsonis,et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging , 2005, Cancer.
[4] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[5] Anand K. Narayan,et al. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study , 2016, Breast Cancer Research and Treatment.
[6] I. Trop,et al. Multimodality breast cancer screening in women with a familial or genetic predisposition. , 2010, Current oncology.
[7] C. Jacobi,et al. Risk Estimation for Healthy Women from Breast Cancer Families , 2004, Cancer Epidemiology Biomarkers & Prevention.
[8] N Risch,et al. Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.
[9] R. Fimmers,et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Petra Macaskill,et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. , 2016, The Lancet. Oncology.
[11] H. Lynch,et al. Hereditary Breast Cancer: Part I. Diagnosing Hereditary Breast Cancer Syndromes , 2008, The breast journal.
[12] T. Helbich,et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] F. Laun,et al. Fast and Noninvasive Characterization of Suspicious Lesions Detected at Breast Cancer X-Ray Screening: Capability of Diffusion-weighted MR Imaging with MIPs. , 2016, Radiology.
[14] Laura Cortesi,et al. Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study): Final Results , 2011, Investigative radiology.
[15] L. Liberman,et al. Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.
[16] Harry J de Koning,et al. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] C. Gatsonis,et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.
[18] Ellen Warner,et al. Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis , 2016, British Journal of Cancer.
[19] J. Ferlay,et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. , 2015, European journal of cancer.
[20] Maximilian Reiser,et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Elizabeth A Morris,et al. The potential of multiparametric MRI of the breast. , 2017, The British journal of radiology.
[22] C. Merritt. Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer , 2009 .
[23] D B Plewes,et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] S. Ciatto,et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. , 2013, The Lancet. Oncology.